Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

Thanks for posting. This article is very important.

This study and its sister study showed none of the drugs studied, Remdesivir,lopinavir/ritonavir, lopinavir/ritonavir–IFN–ß-1a [–IFN–ß-1a is an interferon} and hydroxychloroquine had a significant benefit against moderate to severe Covid19.

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00485-0/fulltext#coronavirus-linkback-header

https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00259-7/fulltext

At this point over 18 months after the beginning of the Covid 19 epidemic we do not have a proven antiviral for patients with moderate to severe Covid 19.

In addition vaccinations have shown their limitations. While it is clear vaccines limit severe illness and death , it is also clear the break through infections mean the vaccinated can not only become sick and die ,but can further spread Covid. The goal of having herd immunity from vaccines is now more difficult to obtain.

Plus the CDC is being criticized for not making the complications of Covid and the vaccines available to the public or others in the health care system.Many suggest looking to England and Israel for more insight into the delta variant surge and vaccinations.

https://www.washingtonpost.com/health/2021/08/18/cdc-data-delay-delta-variant/

https://www.cnbc.com/2021/08/12/herd-immunity-is-mythical-with-the-covid-delta-variant-experts-say.html

It is not surprising the government is focusing on antiviral research.

https://www.hhs.gov/about/news/2021/06/17/biden-administration-invest-3-billion-american-rescue-plan-as-part-covid-19-antiviral-development-strategy.html

Hopefully Brilacidin's phase 2 study will show it is effective against Covid 19.

GLTA,

Farrell